Full Text View
Tabular View
No Study Results Posted
Related Studies
Benzamide Derivates as Treatment of Clozapine-induced Hypersalivation (CIH)
This study has been completed.
Study NCT00534573   Information provided by Beersheva Mental Health Center
First Received: September 24, 2007   Last Updated: November 23, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Clozapine-induced Hypersalivation
Additional conditions recognized in this trial
Sialorrhea
More general conditions related to this trial
Mouth Diseases
Salivary Gland Diseases
Stomatognathic Diseases
Interventions listed in this trial
Amisulpride, Tiapride, Moclobemide
Additional drug interventions recognized in this trial
Moclobemide
Sultopride
Tiapride
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Antidepressive Agents
Antipsychotic Agents
Central Nervous System Agents
Central Nervous System Depressants
Dopamine Agents
Dopamine Antagonists
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Monoamine Oxidase Inhibitors
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Beersheva Mental Health Center
Tirat Carmel Mental Health Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services